Saudat Adamson Fadeyi, PhD, MBA

CANCER FUND Impact Investments® is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at www.cancerfund.com.

Navigating the STEM field can be difficult; especially if you are first generation, have few connections, and/or unsure of career opportunities. An instrumental part of this process is having a mentor for career and professional support. The STEM Hub for Industry Networking and Exchange (S.H.I.N.E.) aims to diversify, build, and prepare future talent pool of STEM professionals. To do so, students from ethnic and racial minority groups are provided the tools to combat barriers of entry into the biotech and pharmaceutical industry primarily through 1:1 mentoring. Our mentors come from a diverse range of careers at numerous companies in the pharmaceutical and biotech field and are passionate about supporting future professionals.

CANCER FUND Impact Investments® is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at www.cancerfund.com.

GV supports innovative founders across multiple stages and sectors, from artificial intelligence and life sciences to consumer platforms, enterprise software, and frontier technology. Launched as Google Ventures in 2009, GV oversees more than $10 billion in assets under management. Our operating partners support founding teams at every stage of company-building across executive talent, design, communications, and marketing. GV is a non-strategic venture capital firm that invests independently from its sole limited partner, Alphabet. We connect startups with Google and Alphabet companies, providing unique access to the world’s best technology and talent. GV has 400 active portfolio companies spanning North America, Europe, and Israel. Our portfolio includes Lightmatter, Stripe, Treeline Biosciences, Vercel, and Wonder, with notable exits including Uber, Nest, Slack, GitLab, Duo Security, Flatiron Health, Lemonade, and One Medical. The firm is headquartered in the San Francisco Bay Area, with offices in Cambridge, New York, and London.

Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions. For those who need relief, we must succeed—their hopes are our aspirations. We act with urgency, ingenuity and integrity as we seek a future free of seizures. At Ovid, we are pursuing small molecule compounds with untapped potential. Applying our nimble, proven approach to accelerate clinical development, we aim to translate our molecules into first-in-class or best-in-class medicines. The patient, clinician and academic communities are our collaborators in every step of development from bench to bedside. Our accomplished team holds a track record of success in making medicines for rare diseases and neurology. Our goal is bold for the communities we serve. For more information, please visit www.ovidrx.com. Review our community guidelines: http://www.ovidrx.com/community-guidelines/

Navigating the STEM field can be difficult; especially if you are first generation, have few connections, and/or unsure of career opportunities. An instrumental part of this process is having a mentor for career and professional support. The STEM Hub for Industry Networking and Exchange (S.H.I.N.E.) aims to diversify, build, and prepare future talent pool of STEM professionals. To do so, students from ethnic and racial minority groups are provided the tools to combat barriers of entry into the biotech and pharmaceutical industry primarily through 1:1 mentoring. Our mentors come from a diverse range of careers at numerous companies in the pharmaceutical and biotech field and are passionate about supporting future professionals.

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more than just a destination. We’re concerned with the journey, and we care deeply about everyone contributing to and benefiting from our own company journey. This means helping people discover the right path for them and carefully guiding colleagues along the way. Read our Community Guidelines: http://bit.ly/2tFyAoj